,45 This is supported by work in mice with Batf3 knockout DCs, which showed that the anti-tumor effects of PD-1 inhibition required both Batf3-dependent DCs cross-presenting antigens to T cells to elicit antigen-specific immunogenic responses and effector T cell attraction to the TME.46 Here, BATF3 is linked to neoplasm.